Completed Lungs & Breathing Genetics & Molecular Biology

A second-generation genome-wide association study for asthma.

In plain English

AI plain-English summary

Asthma genes are being hunted across the DNA of thousands of people to find the biological roots of the disease. Asthma disables and kills people worldwide, and it runs in families. Despite decades of research, many of the specific genetic variants that increase risk remain unknown. This study aims to fill that gap by scanning the entire genomes of a large group of asthmatic adults, children, and people with industrial asthma, comparing them to carefully matched healthy controls. The researchers will use a high-density DNA analysis chip to spot common genetic differences between the groups, then map the most promising regions in detail to find the actual disease-causing changes. If successful, this work will pinpoint the genes and biological pathways that trigger asthma. That knowledge could eventually lead to better diagnostic tests, more targeted treatments, or ways to predict who will develop the disease. It may also reveal why some people develop asthma only after workplace exposures. The study is integrated with a larger European project, so results will feed into a broader understanding of asthma’s genetic architecture. This is fundamental science with clear medical potential, but any new therapies or tests are likely years away.

View original technical description
Asthma is a major cause of disability and death that affects populations world-wide. It has a genetic basis. The study will use a genome-wide association study (GWAS) to identify susceptibility genes for adult and childhood asthma. A panel of 10,000 Caucasian asthmatics and 14,000 matched controls will be genotyped with the Illumina HumanCNV370-Duo DNA Analysis BeadChip. The asthmatic subjects will include cases of adult asthma (n=5,700), childhood asthma (n=3,500), and industrial asthma (n=800). Controls will be matched for geographic origin and environmental exposures. Following analysis of the GWAS by an experienced statistical group, detailed mapping of selected loci will be carried out to identify potential disease-causing variants. The study will be integrated with an existing large-scale investigation of the genetic epidemiology of Asthma in Europe (the GABRIEL project)

View the original record at the funder ↗

Researchers

Cookson (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Fine mapping asthma-susceptibility loci to identify putative targets for drug development
Epigenetics of Severe Asthma
Using genetic data to identify and characterise subtypes of asthma, to inform drug development and precision medicine.
Statistical modelling of longitudinal data from cohort studies to better understand phenotypes of asthma.
Characterising the shared and disease-specific genetic determinants of asthma and COPD

Original classification

Programme Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.